Transcriptional responses define dysregulated immune activation in Hepatitis C (HCV)-naïve recipients of HCV-infected donor kidneys
暂无分享,去创建一个
T. Burke | M. McClain | R. Myers | Xunrong Luo | A. Jackson | J. Steinbrink | S. Sanoff | Jennifer Byrns | A. Mazur | Cameron Miller
[1] D. Gjertson,et al. Acute and Chronic Changes in Gene Expression After CMV DNAemia in Kidney Transplant Recipients , 2021, Frontiers in Immunology.
[2] Xiaochen Bo,et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data , 2021, Innovation.
[3] D. Chaussabel,et al. Transcriptomic Profiling Identifies Neutrophil-Specific Upregulation of Cystatin F as a Marker of Acute Inflammation in Humans , 2021, Frontiers in Immunology.
[4] A. Ungureanu,et al. Host immune response in chronic hepatitis C infection: involvement of cytokines and inflammasomes , 2020, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.
[5] A. Limaye,et al. Respiratory viral infection in lung transplantation induces exosomes that trigger chronic rejection , 2020, The Journal of Heart and Lung Transplantation.
[6] M. Molnar,et al. Transplantation of kidneys from hepatitis C–infected donors to hepatitis C–negative recipients: Single center experience , 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[7] M. Chattergoon,et al. Lessons from the real world: HCV‐infected donor kidney transplantation as standard practice , 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[8] Zeguo Sun,et al. A Peripheral Blood Gene Expression Signature to Diagnose Subclinical Acute Rejection. , 2019, Journal of the American Society of Nephrology : JASN.
[9] A. Kao,et al. Insights into Gene Expression Profile Scores and Rejection in Simultaneous Heart‐Kidney Transplant Patients , 2019, Clinical transplantation.
[10] P. Camp,et al. Heart and Lung Transplants from HCV‐Infected Donors to Uninfected Recipients , 2019, The New England journal of medicine.
[11] Graham M Lord,et al. Development of a multivariable gene-expression signature targeting T-cell-mediated rejection in peripheral blood of kidney transplant recipients validated in cross-sectional and longitudinal samples , 2019, EBioMedicine.
[12] G. Lauer,et al. Dynamic changes in innate immune responses during direct‐acting antiviral therapy for HCV infection , 2019, Journal of viral hepatitis.
[13] C. Rice,et al. Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance , 2018, PLoS pathogens.
[14] R. Hasz,et al. Twelve-Month Outcomes After Transplant of Hepatitis CInfected Kidneys Into Uninfected Recipients , 2018, Annals of Internal Medicine.
[15] Sangsoo Kim,et al. Gene expression profiles for predicting antibody‑mediated kidney allograft rejection: Analysis of GEO datasets. , 2018, International journal of molecular medicine.
[16] J. Felius,et al. Gene expression profiling scores in dual organ transplant patients are similar to those in heart-only recipients. , 2018, Transplant immunology.
[17] J. Jang,et al. Interferon-free treatment for hepatitis C virus infection induces normalization of extrahepatic type I interferon signaling , 2018, Clinical and molecular hepatology.
[18] T. Asselah,et al. Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection , 2018, The New England journal of medicine.
[19] M. Manns,et al. Direct-Acting Antiviral-Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C. , 2016, The Journal of infectious diseases.
[20] T. Berg,et al. Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection. , 2015, The New England journal of medicine.
[21] R. Schooley,et al. Temporal dynamics of inflammatory cytokines/chemokines during sofosbuvir and ribavirin therapy for genotype 2 and 3 hepatitis C infection , 2015, Hepatology.
[22] Young-Joon Kim,et al. Oligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseases , 2015, Experimental & Molecular Medicine.
[23] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[24] Stefan Zeuzem,et al. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. , 2014, The New England journal of medicine.
[25] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[26] K. Volcik,et al. Differentially regulated gene expression associated with hepatitis C virus clearance. , 2013, The Journal of general virology.
[27] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[28] Davis J. McCarthy,et al. Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation , 2012, Nucleic acids research.
[29] James Yee,et al. Gene-expression profiling for rejection surveillance after cardiac transplantation. , 2010, The New England journal of medicine.
[30] Trevor Hastie,et al. Regularization Paths for Generalized Linear Models via Coordinate Descent. , 2010, Journal of statistical software.
[31] L. Carin,et al. Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans. , 2009, Cell host & microbe.
[32] Martin M. Schumacher,et al. Analysis of independent microarray datasets of renal biopsies identifies a robust transcript signature of acute allograft rejection , 2009, Transplant international : official journal of the European Society for Organ Transplantation.
[33] D. Greiner,et al. Viral Infection: A Potent Barrier to Transplantation Tolerance , 2008, Clinical & developmental immunology.
[34] M. Katze,et al. Gene expression patterns that correlate with hepatitis C and early progression to fibrosis in liver transplant recipients. , 2006, Gastroenterology.
[35] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[36] L. Wodicka,et al. Genomic analysis of the host response to hepatitis C virus infection , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[37] H. Rollag,et al. The Impact of Cytomegalovirus Infection and Disease on Rejection Episodes in Renal Allograft Recipients , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[38] J. Parkin,et al. An overview of the immune system , 2001, The Lancet.